Published in Neurobiol Aging on December 24, 2002
Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med (2011) 3.28
The GSK3 hypothesis of Alzheimer's disease. J Neurochem (2007) 3.16
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation (2005) 1.64
Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation (2012) 1.57
IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice. J Immunol (2010) 1.55
The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm (Vienna) (2006) 1.55
Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease. Biol Psychiatry (2014) 1.54
Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center. J Neuropathol Exp Neurol (2013) 1.52
RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J (2009) 1.39
Single cell gene expression profiling in Alzheimer's disease. NeuroRx (2006) 1.22
Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles. Brain (2013) 1.20
GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS One (2012) 1.18
Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease. J Neuroinflammation (2005) 1.16
Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). J Alzheimers Dis (2009) 1.15
Genes and pathways underlying regional and cell type changes in Alzheimer's disease. Genome Med (2013) 1.12
Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int J Alzheimers Dis (2010) 1.05
Innate immunity in Alzheimer's disease: a complex affair. CNS Neurol Disord Drug Targets (2013) 1.05
Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease. J Neuropathol Exp Neurol (2013) 1.03
Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy. J Neuropathol Exp Neurol (2010) 0.98
Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease. Neuropathol Appl Neurobiol (2012) 0.98
The role of inflammatory processes in Alzheimer's disease. Inflammopharmacology (2012) 0.92
Microglia in Alzheimer brain: a neuropathological perspective. Int J Alzheimers Dis (2012) 0.87
In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [(18)F]-FEPPA. Mol Psychiatry (2015) 0.87
Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro. Biochemistry (2010) 0.87
Cortical interneurons become activated by deafferentation and instruct the apoptosis of pyramidal neurons. Proc Natl Acad Sci U S A (2004) 0.87
Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship. Neurocase (2012) 0.86
Characterisation of amyloid-induced inflammatory responses in the rat retina. Exp Brain Res (2011) 0.85
Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging. J Neuroinflammation (2014) 0.85
DOCK2 is a microglial specific regulator of central nervous system innate immunity found in normal and Alzheimer's disease brain. Am J Pathol (2009) 0.84
Is there a causal link between inflammation and dementia? Biomed Res Int (2013) 0.84
Inflammatory proteins in plasma are associated with severity of Alzheimer's disease. PLoS One (2013) 0.84
Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2007) 0.84
Metabolic changes in the anterior and posterior cingulate cortices of the normal aging brain: proton magnetic resonance spectroscopy study at 3 T. Age (Dordr) (2013) 0.82
Neuroinflammation in Alzheimer's disease wanes with age. J Neuroinflammation (2011) 0.82
Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile. PLoS One (2015) 0.80
Staging anti-inflammatory therapy in Alzheimer's disease. Front Aging Neurosci (2010) 0.79
Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer's disease pathology. J Neuroinflammation (2016) 0.78
Clinical dementia rating performed several years prior to death predicts regional Alzheimer's neuropathology. Dement Geriatr Cogn Disord (2008) 0.78
Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury: Anti-inflammatory effects. Neural Regen Res (2012) 0.77
Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice. J Alzheimers Dis (2017) 0.75
Astrocyte mediated MMP-9 activation in the synapse dysfunction: An implication in Alzheimer disease. Ther Targets Neurol Dis (2015) 0.75
Regional and Gender Study of Neuronal Density in Brain during Aging and in Alzheimer's Disease. Front Aging Neurosci (2016) 0.75
Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke. J Neuroinflammation (2017) 0.75
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science (2004) 4.97
The built environment and obesity: a systematic review of the epidemiologic evidence. Health Place (2009) 3.98
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol (2014) 3.75
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A (2004) 3.61
Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron (2009) 3.15
Screening for dementia by telephone using the memory impairment screen. J Am Geriatr Soc (2003) 2.92
Cutaneous allodynia in the migraine population. Ann Neurol (2008) 2.75
Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann Neurol (2006) 2.68
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68
Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology (2013) 2.61
Repeat expansion in C9ORF72 in Alzheimer's disease. N Engl J Med (2012) 2.58
Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc Natl Acad Sci U S A (2005) 2.45
Association of body mass index and weight change with all-cause mortality in the elderly. Am J Epidemiol (2006) 2.40
Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo. J Neurosci (2012) 2.35
Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol Aging (2004) 2.31
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A (2013) 2.31
Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann Neurol (2010) 2.09
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Prediction modeling using EHR data: challenges, strategies, and a comparison of machine learning approaches. Med Care (2010) 2.01
Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache (2008) 1.95
Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction (2010) 1.95
Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo. J Neurosci (2012) 1.95
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One (2011) 1.93
EHR safety: the way forward to safe and effective systems. J Am Med Inform Assoc (2008) 1.90
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proc Natl Acad Sci U S A (2010) 1.81
Disparities in cognitive functioning by race/ethnicity in the Baltimore Memory Study. Environ Health Perspect (2004) 1.77
Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells. J Neurosci (2005) 1.75
Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology (2004) 1.75
Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuropathol Exp Neurol (2005) 1.74
APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology (2009) 1.74
Back pain exacerbations and lost productive time costs in United States workers. Spine (Phila Pa 1976) (2006) 1.72
Migraine and autonomic nervous system function: a population-based, case-control study. Neurology (2002) 1.71
Urinary incontinence in women: variation in prevalence estimates and risk factors. Obstet Gynecol (2008) 1.67
Association of chromosome 9p21 SNPs with cardiovascular phenotypes in morbid obesity using electronic health record data. Genomic Med (2008) 1.65
Valproic acid prevents brain injury in a canine model of hypothermic circulatory arrest: a promising new approach to neuroprotection during cardiac surgery. Ann Thorac Surg (2006) 1.64
Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci (2004) 1.60
Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol (2005) 1.58
Estimated economic costs of overactive bladder in the United States. Urology (2003) 1.58
Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms. Hum Mol Genet (2007) 1.56
Arc/Arg3.1 regulates an endosomal pathway essential for activity-dependent β-amyloid generation. Cell (2011) 1.52
Neuronal hypertrophy in asymptomatic Alzheimer disease. J Neuropathol Exp Neurol (2008) 1.49
Modeling age and retest processes in longitudinal studies of cognitive abilities. Psychol Aging (2004) 1.48
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Combining knowledge and data driven insights for identifying risk factors using electronic health records. AMIA Annu Symp Proc (2012) 1.46
Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study. Menopause (2006) 1.46
Multivariate modeling of age and retest in longitudinal studies of cognitive abilities. Psychol Aging (2005) 1.45
Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging (2004) 1.44
Head or neck injury increases the risk of chronic daily headache: a population-based study. Neurology (2007) 1.43
In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults. Arch Neurol (2011) 1.40
Algorithms, clinical practice guidelines, and standardized clinical assessment and management plans: evidence-based patient management standards in evolution. Acad Med (2015) 1.39
Abnormal EEGs in cognitively and physically healthy oldest old: findings from the 90+ study. J Clin Neurophysiol (2010) 1.39
Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol Aging (2007) 1.34
Association of morbid obesity with FTO and INSIG2 allelic variants. Arch Surg (2008) 1.34
Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation. J Neurosci (2004) 1.31
A population-based clinicopathological study in the oldest-old: the 90+ study. Curr Alzheimer Res (2012) 1.31
Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old. Brain (2011) 1.29
NDRG2: a novel Alzheimer's disease associated protein. Neurobiol Dis (2004) 1.29
Synaptic proteins, neuropathology and cognitive status in the oldest-old. Neurobiol Aging (2007) 1.28
Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis (2011) 1.26
Body mass index and the built and social environments in children and adolescents using electronic health records. Am J Prev Med (2011) 1.26
How Geisinger's advanced medical home model argues the case for rapid-cycle innovation. Health Aff (Millwood) (2010) 1.25
Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis. J Allergy Clin Immunol (2013) 1.24
The longitudinal association of lead with blood pressure. Epidemiology (2003) 1.24
Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Prev Med (2006) 1.22
The epidemiology and impact of migraine. Curr Neurol Neurosci Rep (2004) 1.21
S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. Proc Natl Acad Sci U S A (2009) 1.20
Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2. Alzheimers Dement (2011) 1.19
Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol (2013) 1.19
Morphometry of the human substantia nigra in ageing and Parkinson's disease. Acta Neuropathol (2008) 1.18
PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol (2015) 1.17
Predictors of first-fill adherence for patients with hypertension. Am J Hypertens (2009) 1.17
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol Aging (2010) 1.16
Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). J Alzheimers Dis (2009) 1.15
Findings on brain MRI from research studies of occupational exposure to known neurotoxicants. AJR Am J Roentgenol (2006) 1.14
Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice. Mol Neurodegener (2013) 1.13
Soccer heading is associated with white matter microstructural and cognitive abnormalities. Radiology (2013) 1.12
Nicotinic acetylcholine receptor genes on chromosome 15q25.1 are associated with nicotine and opioid dependence severity. Hum Genet (2010) 1.12
Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model. Hum Mol Genet (2010) 1.12
Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med (2008) 1.12
Relations of brain volumes with cognitive function in males 45 years and older with past lead exposure. Neuroimage (2007) 1.12
Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia. Neurology (2012) 1.12
MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet (2012) 1.11
PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Hum Mol Genet (2011) 1.11
Association of FKBP5, COMT and CHRNA5 polymorphisms with PTSD among outpatients at risk for PTSD. Psychiatry Res (2011) 1.11
Apolipoprotein E epsilon 4 and short-term recovery from predominantly mild brain injury. Neurology (2002) 1.10
Neurodegenerative phenotypes in an A53T α-synuclein transgenic mouse model are independent of LRRK2. Hum Mol Genet (2012) 1.10
Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques. Acta Neuropathol (2012) 1.09
Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old. Alzheimers Dement (2009) 1.09
Postdischarge monitoring using interactive voice response system reduces 30-day readmission rates in a case-managed Medicare population. Med Care (2012) 1.09
ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol (2014) 1.07
Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging. Alzheimers Dement (2005) 1.07
Activities and mortality in the elderly: the Leisure World cohort study. J Gerontol A Biol Sci Med Sci (2011) 1.06